Li X, Du J R, Yu Y, et al. Tanshinone ⅡA inhibits smooth muscle proliferation and intimal hyperplasia in the rat carotid balloon-injured model through inhibition of MAPK signaling pathway[J]. J Ethnopharmacol, 2010, 129(2): 273.
Zhang Y, Wei L, Sun D, et al. Tanshinone ⅡA pretreatment protects myocardium against ischaemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway in diabetic rats[J]. Diabetes Obes Metab, 2010, 12(4):316.
Xu S, Little P J, Lan T, et al. Tanshinone ⅡA attenuates and stabilizes atherosclerotic plaques in apolipoprotein-E knockout mice fed a high cholesterol diet[J]. Arch Biochem Biophys, 2011, 515(1/2): 72.
[12]
Gong Z, Huang C, Sheng X, et al. The role of tanshinone ⅡA in the treatment of obesity through peroxisome proliferator-activated receptor gamma antagonism[J]. Endocrinology, 2009, 150(1): 104.
[13]
Liu Z, Wang J, Huang E, et al. Tanshinone ⅡA suppresses cholesterol accumulation in human macrophages: role of heme oxygenase-1[J]. J Lipid Res, 2014, 55(2): 201.
Jiang F L, Leo S, Wang X G, et al. Effect of tanshinone ⅡA on cardiomyocyte hypertrophy and apoptosis in spontaneously hypertensive rats[J]. Exp Ther Med, 2013, 6(6): 1517.
Wu L C, Lin X, Sun H. TanshinoneⅡA protects rabbits against LPS-induced disseminated intravascular coagulation (DIC)[J]. Acta Pharmacol Sin, 2012, 33(10):1254.
Stumpf C, Fan Q, Hintermann C, et al. Anti-inflammatory effects of danshen on human vascular endothelial cells in culture[J]. Am J Chin Med, 2013, 41(5):1065.
[28]
Tang C, Xue H L, Bai C L, et al. Regulation of adhesion molecules expression in TNF-α- stimulated brain microvascular endothelial cells by tanshinone ⅡA: involvement of NF-κB and ROS generation[J]. Phytother Res, 2011, 25(3):376.
[29]
Ren Z H, Tong Y H, Xu W, et al. Tanshinone ⅡA attenuates inflammatory responses of rats with myocardial infarction by reducing MCP-1 expression[J]. Phytomedicine, 2010, 17(3/4): 212.
Chan P, Chen Y C, Lin L J, et al. Tanshinone ⅡA attenuates H2O2-induced injury in human umbilical vein endothelial cells[J]. Am J Chin Med, 2012, 40(6):1307.
[33]
Jia L Q, Yang G L, Ren L, et al. Tanshinone ⅡA reduces apoptosis induced by hydrogen peroxide in the human endothelium-derived EA.hy926 cells[J].J Ethnopharmacol, 2012, 143(1): 100.
[34]
Wang P, Zhou S, Xu L, et al. Hydrogen peroxide-mediated oxidative stress and collagen synthesis in cardiac fibroblasts: blockade by tanshinone ⅡA [J]. J Ethnopharmacol, 2013, 145(1): 152.
[35]
Yang R, Liu A, Ma X, et al. Sodium tanshinone ⅡA sulfonate protects cardiomyocytes against oxidative stress-mediated apoptosis through inhibiting JNK activation[J]. J Cardiovasc Pharmacol, 2008, 4: 396.
[36]
Shan H, Li X, Pan Z, et al. Tanshinone ⅡA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA-1[J]. Br J Pharmacol, 2009, 158(5): 1227.
[37]
Sun D D, Wang H C, Wang X B, et al. Tanshinone ⅡA: a new activator of human cardiac KCNQ1/KCNE1 (I(Ks)) potassium channels[J]. Eur J Pharmacol, 2008, 590(1/3):317.
Wu G B, Zhou E X, Qing D X. Tanshinone ⅡA elicited vasodilation in rat coronary arteriole: roles of nitric oxide and potassium channels[J]. Eur J Pharmacol, 2009, 617(1/3):102.
[41]
Zhang Y, Zhang L, Chu W, et al. Tanshinone ⅡA inhibits miR-1 expression through p38 MAPK signal pathway in post-infarction rat cardiomyocytes[J]. Cell Physiol Biochem, 2010, 26(6): 991.
[42]
Zhang L, Wu Y, Li Y, et al. Tanshinone ⅡA improves miR-133 expression through MAPK ERK1/2 pathway in hypoxic cardiac myocytes[J]. Cell Physiol Biochem, 2012, 30(4): 843.
[43]
Jin H J, Li C G. Tanshinone ⅡA and cryptotanshinone prevent mitochondrial dysfunction in hypoxia-induced H9c2 cells: association to mitochondrial ROS, intracellular nitric oxide, and calcium levels[J]. Evid Based Complement Alternat Med, 2013,doi:10.1155/2013/610694.
[44]
Hausenloy D J, Yellon D M. Myocardial ischemia-reperfusion injury: a neglected therapeutic target[J]. J Clin Invest, 2013, 123(1): 92.
Fu J, Huang H, Liu J, et al. Tanshinone ⅡA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis[J]. Eur J Pharmacol, 2007, 568(1-3): 213.
[49]
Wang X, Wang Y, Jiang M, et al. Differential cardioprotective effects of salvianolic acid and tanshinone on acute myocardial infarction are mediated by unique signaling pathways[J]. J Ethnopharmacol, 2011, 135(3):662.
[50]
Xu W, Yang J, Wu L M. Cardioprotective effects of tanshinoneⅡA on myocardial ischemia injury in rats[J]. Pharmazie, 2009, 64(5):332.
